Literature DB >> 31485804

Food, Acid Supplementation and Drug Absorption - a Complicated Gastric Mix: a Randomized Control Trial.

Dalga D Surofchy1, Lynda A Frassetto2, Leslie Z Benet3.   

Abstract

PURPOSE: The purpose of this study was to determine the impact of food on gastric pH and the ability of over the counter betaine hydrochloride (BHCl) acid to reacidify gastric pH after food-induced elevations in gastric pH.
METHODS: This open-label cross over clinical study (NCT02758015) included 9 subjects who were randomly assigned to one of 16 possible, 4-period cross-over sequences to determine the impact and relationship of food and gastric pH with acid supplementation. Subjects were administered various doses (1500 mg, 3000 mg and 4500 mg) of betaine hydrochloride (BHCl) to determine the ability of acid supplementation to reacidify gastric pH after the elevation of gastric pH caused by the ingestion of food.
RESULTS: Following the administration of food and the resulting elevation in gastric pH, time to return to baseline gastric pH levels without acid supplementation was 49.7 ± 14.0 min. Administering 4500 mg of BHCl acid in capsules was able to reacidify gastric pH levels back to baseline following the administration of food in approximately 17.3 ± 5.9 min. AUCpH of each treatment were similar and not statistically different. Mean max pH following the administration of food was 3.20 ± 0.55.
CONCLUSION: The ability of food to elevate and maintain gastric pH levels in the presence of acid supplementation was made evident throughout the study. A 4500 mg dose of BHCl was required to reacidify gastric pH after the administration of food. This study details the difficulty faced by clinicians in dosing a poorly soluble, weakly basic drug to patients receiving acid reducing agents where administration with food is recommended to avoid gastric side effects. TRIAL REGISTRATION: https://clinicaltrials.gov/ct2/show/NCT02758015.

Entities:  

Keywords:  betaine hydrochloride; gastric pH; gastric reacidification; meal effects

Mesh:

Substances:

Year:  2019        PMID: 31485804      PMCID: PMC7484952          DOI: 10.1007/s11095-019-2693-5

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  Impact of food intake on the antisecretory effect of low-dose ranitidine and famotidine.

Authors:  P Netzer; K Eschenmoser; F Halter; W Inauen
Journal:  Aliment Pharmacol Ther       Date:  1999-03       Impact factor: 8.171

2.  Effect of low-dose omeprazole (20 mg daily) on the pharmacokinetics of multiple-dose atazanavir with ritonavir in healthy subjects.

Authors:  Li Zhu; Anna Persson; Lisa Mahnke; Timothy Eley; Tong Li; Xiaohui Xu; Sangeeta Agarwala; Jeffrey Dragone; Richard Bertz
Journal:  J Clin Pharmacol       Date:  2010-05-10       Impact factor: 3.126

3.  Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids.

Authors:  Paula Trumbo; Sandra Schlicker; Allison A Yates; Mary Poos
Journal:  J Am Diet Assoc       Date:  2002-11

4.  pH dependence of organic anion-transporting polypeptide 2B1 in Caco-2 cells: potential role in antiretroviral drug oral bioavailability and drug-drug interactions.

Authors:  Olena Kis; Jason A Zastre; Manisha Ramaswamy; Reina Bendayan
Journal:  J Pharmacol Exp Ther       Date:  2010-05-27       Impact factor: 4.030

5.  Modification of gastric pH with oral glutamic acid hydrochloride.

Authors:  M J Knapp; R R Berardi; J B Dressman; J M Rider; P L Carver
Journal:  Clin Pharm       Date:  1991-11

6.  Effect of pH and comedication on gastrointestinal absorption of posaconazole: monitoring of intraluminal and plasma drug concentrations.

Authors:  Jeroen Walravens; Joachim Brouwers; Isabel Spriet; Jan Tack; Pieter Annaert; Patrick Augustijns
Journal:  Clin Pharmacokinet       Date:  2011-11-01       Impact factor: 6.447

Review 7.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

8.  Method to recover a lipophilic drug from hydroxypropyl methylcellulose matrix tablets.

Authors:  R O Williams; M A Sykora; V Mahaguna
Journal:  AAPS PharmSciTech       Date:  2001-06-09       Impact factor: 3.246

9.  Phase I study of the effect of gastric acid pH modulators on the bioavailability of oral dasatinib in healthy subjects.

Authors:  Timothy Eley; Feng R Luo; Shruti Agrawal; Ashish Sanil; James Manning; Tong Li; Anne Blackwood-Chirchir; Richard Bertz
Journal:  J Clin Pharmacol       Date:  2009-04-24       Impact factor: 3.126

Review 10.  Drug interactions between HIV protease inhibitors and acid-reducing agents.

Authors:  Ronald W Falcon; Thomas N Kakuda
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.